http://www.biospace.comBioSpace RSS GeneratorSat, 25 May 2013 03:41:16 GMT20http://rss.biospace.com/images/BSPLogo.gifhttp://www.BioSpace.com/news.aspx?SectionId=1Copyright (C) 2011http://www.businesswire.com/portal/site/biospace2/index.jsp?ndmViewId=news_view&newsId=20111220006621&newsLang=enIRVINE, Calif.--(BUSINESS WIRE)--Syprosoft Engineering announced today the successful completion of the design of an innovative disposable drug delivery device for Surgin Inc. The design process included fluid flow analysis, stress calculations, materials selection, ergonomics, rapid prototyping and pre-clinical bench-top testing. The entire effort was completed in about five months.Wed, 21 Dec 2011 12:00:00 AM GMThttp://www.businesswire.com/portal/site/biospace2/template.PAGE/menuitem.ce58e8202d51f40bfcb16f10c0908a0c/index.jsp?ndmViewId=news_view&newsId=20111024005014&newsLang=enLIMERICK, Pa.--(BUSINESS WIRE)--Teleflex Incorporated (NYSE:TFX) today announced the launch of the ArrowADVANTAGE5 pressure-injectable peripherally inserted central catheter (PICC). ArrowADVANTAGE5 provides features clinicians have come to expect in a PICC, plus five unique advantages. The design was developed for clinician ease-of-use, smooth insertion and patient comfort. Mon, 24 Oct 2011 12:00:00 AM GMThttp://www.businesswire.com/portal/site/biospace/index.jsp?ndmViewId=news_view&newsId=20111024005417&newsLang=enPORTLAND, Ore.--(BUSINESS WIRE)--Bioject Medical Technologies Inc. (OTCBB:BJCT), a leading developer of needle-free drug delivery systems, today announced that the Food and Drug Administration (FDA) has issued a communication on the use of jet injectors with influenza vaccines. The FDA is advising health care professionals not to use injector devices to administer influenza vaccines. Furthermore, the...Mon, 24 Oct 2011 12:00:00 AM GMThttp://shared.web.emory.edu/whsc/news/releases/2011/07/h1n1-microneedle-vaccine-protects-better-than-injection-.htmlA vaccine delivered to the skin using a microneedle patch gives better protection against the H1N1 influenza virus than a vaccine delivered through subcutaneous or intramuscular injection, researchers from Emory and Georgia Tech have found. Their research is published online in the Journal of Infectious Diseases.Tue, 12 Jul 2011 12:00:00 AM GMThttp://www.medicalnewstoday.com/releases/230190.phpA team of engineers and scientists at the University of British Columbia has developed a device that can be implanted behind the eye for controlled and on-demand release of drugs to treat retinal damage caused by diabetes. Diabetic retinopathy is the leading cause of vision loss among patients with diabetes. The disease is caused by the unwanted growth of capillary cells in the retina, which in its...Fri, 01 Jul 2011 12:00:00 AM GMThttp://www.sciencedaily.com/releases/2010/07/100727201526.htmEurekAlert! -- Using chemical "nanoblasts" that punch tiny holes in the protective membranes of cells, researchers have demonstrated a new technique for getting therapeutic small molecules, proteins and DNA directly into living cells. Wed, 28 Jul 2010 12:00:00 AM GMThttp://www.biospace.com/news_story.aspx?StoryID=184126&full=1AUSTIN, Texas</span>, <span class"xn-chron">June 14</span> /PRNewswire/ -- Savara, Inc., an inhalation drug delivery company, today announced that it has been chosen by the state of <span class"xn-location">Texas</span> as the recipient of a commercialization award funded through the Texas Emerging Technology Fund (ETF). The company, which produces novel respiratory therapeutics, will receive a ...Mon, 14 Jun 2010 12:00:00 AM GMThttp://www.biospace.com/news_story.aspx?StoryID=183334&full=1NEW YORK, June 7 /PRNewswire/ -- Avista Capital Partners ("Avista"), a leading private equity firm, today announced it has committed to invest $48.5 million in OptiNose ("OptiNose" or "the Company"). OptiNose has developed an innovative nasal drug delivery technology that enables administration of drugs deep in the nasal cavity, enabling the treatment of both local and systemic disease. In conjunction...Tue, 08 Jun 2010 12:00:00 AM GMThttp://futurity.org/top-stories/nanosponge-delivers-better-than-injection/Futurity -- When loaded with an anticancer drug, a delivery system based on a novel material called nanosponge is three to five times more effective at reducing tumor growth than direct injection.Fri, 04 Jun 2010 12:00:00 AM GMThttp://www.newsonfeeds.com/article/11822530/Nanoliposomes%20engineered%20to%20deliver%20therapeutic%20drugs%20that%20kill%20malignant%20cellsNews-Medical -- A new way to deliver cancer-fighting drugs using tiny particles made from lipids and chemotherapy drugs may have the power to knock out malignancies with a one-two punch. The strategy holds promise for patients with many different kinds of cancers.Tue, 25 May 2010 12:00:00 AM GMThttp://www.biospace.com/news_story.aspx?StoryID=180118&full=1BETHLEHEM, Pa.</span>, <span class"xn-chron">May 11</span> /PRNewswire/ -- The U.S. Food and Drug Administration recently approved an application that permits B. Braun Medical Inc. (B. Braun) to deliver FDA-approved <a href"http://www.duplex.bbraunusa.com/PR">1g and 2g Cefepime for Injection USP and Dextrose Injection USP in B. Braun's DUPLEX Drug Delivery System</a>.</p><p>(Logo: <a href"http...Tue, 11 May 2010 12:00:00 AM GMThttp://www.biospace.com/news_story.aspx?StoryID=179876&full=1Glasgow, U.K., 6th May 2010 Bio-Images Research Ltd. has developed a novel capsule system for site-specific delivery of drugs.<p></p>The Hydrophilic Sandwich (HS) capsule is a capsule within a capsule, with the formulation of interest in the inner capsule and a layer of gelling, erodible polymer located within the inter-capsule space. With judicious choice of the density of the polymer layer...Fri, 07 May 2010 12:00:00 AM GMThttp://www.biospace.com/news_story.aspx?StoryID=177547&full=1<p>- Positive Pharmacokinetic Study Results on First INTELLITAB(TM) Product Demonstrates Proof-of-Concept -</p><p></p><p>LAVAL, QC, April 21 /PRNewswire-FirstCall/ - Labopharm Inc. today introduced INTELLITAB(TM), the brand name for its proprietary abuse and misuse-deterrent technology platform. The INTELLITAB(TM) platform, which can deliver one or more therapeutic drugs in combination over periods...Wed, 21 Apr 2010 12:00:00 AM GMThttp://www.reuters.com/article/idCNLDE63I06D20100419?rpc=44DUBLIN--(BUSINESS WIRE)--Elan Corporation, plc has decided to explore the possibility of a separation of its Elan Drug Technologies (EDT) business. If executed, any transaction would create two distinct publicly listed companies: Elan BioNeurology and EDT, with each entity being a leader in its field of expertise. The purpose of this exploration is to accurately assess the opportunity and impact on...Mon, 19 Apr 2010 12:00:00 AM GMThttp://www.biospace.com/news_story.aspx?StoryID=176732&full=1<p></p><p>SILVER SPRING, Md., April 13 /PRNewswire-USNewswire/ -- The U.S. Food and Drug Administration today announced, in accordance with longstanding U.S. obligations under the Montreal Protocol on Substances that Deplete the Ozone Layer, seven metered-dose inhalers (MDI) used to treat asthma and chronic obstructive pulmonary disease (COPD) will be gradually removed from the U.S. marketplace. These...Wed, 14 Apr 2010 12:00:00 AM GMThttp://www.upi.com/Science_News/2010/03/22/Nano-DNA-system-may-deliver-medicines/UPI-36951269291373/ScienceDaily (Apr. 9, 2010) A team of McGill Chemistry Department researchers led by Dr. Hanadi Sleiman has achieved a major breakthrough in the development of nanotubes -- tiny "magic bullets" that could one day deliver drugs to specific diseased cells. Sleiman explains that the research involves taking DNA out of its biological context. So rather than being used as the genetic code for life, it...Fri, 09 Apr 2010 12:00:00 AM GMThttp://www.biospace.com/news_story.aspx?StoryID=176017&full=1MENLO PARK, Calif.--(BUSINESS WIRE)--iScience Interventional, pioneers of site-specific therapies for anterior and posterior ocular diseases, announced it has signed a collaborative agreement with Centocor R&D, Inc. iScience will supply micro-catheter delivery systems for use in the clinical evaluation of cell therapies used in the treatment of retinal degeneration.</p><p>We are pleased to work...Wed, 07 Apr 2010 12:00:00 AM GMThttp://www.biospace.com/news_story.aspx?StoryID=175887&full=1LEWISBERRY, Pa., April 5 /PRNewswire-FirstCall/ -- Unilife Corporation ("Unilife" or "Company") (Nasdaq: UNIS; ASX: UNS) today announced it has received from the U.S. Food and Drug Administration (FDA) 510(k) market clearance for the Unitract 1mL Insulin Syringes assembled at its Lewisberry, PA manufacturing facility. </p><p>The Unitract range of 1mL syringes is the world's first and only...Tue, 06 Apr 2010 12:00:00 AM GMThttp://www.eurekalert.org/pub_releases/2010-03/acs-cll030910.phpEurekAlert -- The popular dietary supplement vitamin E, loaded into special medicated contact lenses, can keep glaucoma medicine near the eye where it can treat that common disease almost 100 times longer than possible with current commercial lenses, scientists reported here today. In a presentation at the 239th National Meeting of the American Chemical Society (ACS), they described use of vitamin...Thu, 25 Mar 2010 12:00:00 AM GMThttp://www.reuters.com/article/idUSTRE62K1BK20100321CHICAGO (Reuters) - U.S. researchers have developed tiny nanoparticle robots that can travel through a patient's blood and into tumors where they deliver a therapy that turns off an important cancer gene.Mon, 22 Mar 2010 12:00:00 AM GMThttp://www.mcgill.ca/newsroom/news/item/?item_id=115523McGill University -- A team of McGill Chemistry Department researchers led by Dr. Hanadi Sleiman has achieved a major breakthrough in the development of nanotubes - tiny "magic bullets" that could one day deliver drugs to specific diseased cells. Sleiman explains that the research involves taking DNA out of its biological context. So rather than being used as the genetic code for life, it becomes a...Thu, 18 Mar 2010 12:00:00 AM GMThttp://www.biospace.com/news_story.aspx?StoryID=173243&full=1COCOA, Fla., March 9 /PRNewswire/ -- GeNO LLC (www.genollc.com) a privately held, advanced development-stage technology company, today announced that the U.S. Food and Drug Administration (FDA) has granted clearance of its Investigational New Drug (IND) application for its stand-alone gas cylinder Nitrosyl Delivery Platform (NDP). The initial indication to be studied for nitric oxide delivered via...Tue, 09 Mar 2010 12:00:00 AM GMThttp://www.sciencedaily.com/releases/2010/02/100224134327.htm<!-- AddThis Button BEGIN --><script type"text/javascript">var addthis_pub"bdwyer";</script><a href"http://www.addthis.com/bookmark.php?v20" onmouseover"return addthis_open(this, '', '[URL]', '[TITLE]')" onmouseout"addthis_close()" onclick"return addthis_sendto()"><img src"http://s7.addthis.com/static/btn/sm-share-en.gif" width"83" height"16" alt"Bookmark and Share" style"border:0...Thu, 25 Feb 2010 12:00:00 AM GMThttp://www.physorg.com/news185190665.html<!-- AddThis Button BEGIN --><script type"text/javascript">var addthis_pub"bdwyer";</script><a href"http://www.addthis.com/bookmark.php?v20" onmouseover"return addthis_open(this, '', '[URL]', '[TITLE]')" onmouseout"addthis_close()" onclick"return addthis_sendto()"><img src"http://s7.addthis.com/static/btn/sm-share-en.gif" width"83" height"16" alt"Bookmark and Share" style"border:0...Fri, 12 Feb 2010 12:00:00 AM GMThttp://www.biospace.com/news_story.aspx?StoryID=166424&full=1<p></p><p>LAKE FOREST, Ill., Dec. 23 /PRNewswire-FirstCall/ -- Hospira, Inc. , a leading global specialty pharmaceutical and medication delivery company, today announced that the company will present at the J.P. Morgan 28th Annual Healthcare Conference on Wednesday, Jan. 13, 2010, in San Francisco.</p><p></p><p></p><p>About Hospira</p><p>Hospira, Inc. is a global specialty pharmaceutical and medication...Mon, 28 Dec 2009 12:00:00 AM GMThttp://www.medicalnewstoday.com/articles/174720.php<!-- AddThis Button BEGIN --><script type"text/javascript">var addthis_pub"bdwyer";</script><a href"http://www.addthis.com/bookmark.php?v20" onmouseover"return addthis_open(this, '', '[URL]', '[TITLE]')" onmouseout"addthis_close()" onclick"return addthis_sendto()"><img src"http://s7.addthis.com/static/btn/sm-share-en.gif" width"83" height"16" alt"Bookmark and Share" style"border:0...Wed, 23 Dec 2009 12:00:00 AM GMThttp://www.biospace.com/news_story.aspx?StoryID=165977&full=1<!-- AddThis Button BEGIN --><script type"text/javascript">var addthis_pub"bdwyer";</script><a href"http://www.addthis.com/bookmark.php?v20" onmouseover"return addthis_open(this, '', '[URL]', '[TITLE]')" onmouseout"addthis_close()" onclick"return addthis_sendto()"><img src"http://s7.addthis.com/static/btn/sm-share-en.gif" width"83" height"16" alt"Bookmark and Share" style"border:0...Fri, 18 Dec 2009 12:00:00 AM GMThttp://www.biospace.com/news_story.aspx?StoryID=165677&full=1<!-- AddThis Button BEGIN --><script type"text/javascript">var addthis_pub"bdwyer";</script><a href"http://www.addthis.com/bookmark.php?v20" onmouseover"return addthis_open(this, '', '[URL]', '[TITLE]')" onmouseout"addthis_close()" onclick"return addthis_sendto()"><img src"http://s7.addthis.com/static/btn/sm-share-en.gif" width"83" height"16" alt"Bookmark and Share" style"border:0...Wed, 16 Dec 2009 12:00:00 AM GMThttp://www.physorg.com/news180027243.html<!-- AddThis Button BEGIN --><script type"text/javascript">var addthis_pub"bdwyer";</script><a href"http://www.addthis.com/bookmark.php?v20" onmouseover"return addthis_open(this, '', '[URL]', '[TITLE]')" onmouseout"addthis_close()" onclick"return addthis_sendto()"><img src"http://s7.addthis.com/static/btn/sm-share-en.gif" width"83" height"16" alt"Bookmark and Share" style"border:0...Tue, 15 Dec 2009 12:00:00 AM GMThttp://www.eurekalert.org/pub_releases/2009-11/aiop-nbg110409.php<!-- AddThis Button BEGIN --><script type"text/javascript">var addthis_pub"bdwyer";</script><a href"http://www.addthis.com/bookmark.php?v20" onmouseover"return addthis_open(this, '', '[URL]', '[TITLE]')" onmouseout"addthis_close()" onclick"return addthis_sendto()"><img src"http://s7.addthis.com/static/btn/sm-share-en.gif" width"83" height"16" alt"Bookmark and Share" style"border:0...Tue, 10 Nov 2009 12:00:00 AM GMThttp://www.medgadget.com/archives/2009/11/ieee_spectrum_flexible_microsystems_deliver_drugs_through_the_ear.html<!-- AddThis Button BEGIN --><script type"text/javascript">var addthis_pub"bdwyer";</script><a href"http://www.addthis.com/bookmark.php?v20" onmouseover"return addthis_open(this, '', '[URL]', '[TITLE]')" onmouseout"addthis_close()" onclick"return addthis_sendto()"><img src"http://s7.addthis.com/static/btn/sm-share-en.gif" width"83" height"16" alt"Bookmark and Share" style"border:0...Tue, 10 Nov 2009 12:00:00 AM GMThttp://www.sciencedaily.com/releases/2009/10/091028114027.htmScienceDaily (Nov. 2, 2009) Scientists in California are reporting development of a new generation of the microcapsules used in carbon-free copy paper, in which capsules burst and release ink with pressure from a pen. The new microcapsules burst when exposed to light, releasing their contents in ways that could have wide-ranging commercial uses from home and personal care to medicine.Mon, 02 Nov 2009 12:00:00 AM GMThttp://www.eurekalert.org/pub_releases/2009-11/du-ddn103009.phpEurekAlert -- Going smaller could bring better results, especially when it comes to cancer-fighting drugs. Duke University bioengineers have developed a simple and inexpensive method for loading cancer drug payloads into nano-scale delivery vehicles and demonstrated in animal models that this new nanoformulation can eliminate tumors after a single treatment. After delivering the drug to the tumor...Mon, 02 Nov 2009 12:00:00 AM GMThttp://www.sciencedaily.com/releases/2009/11/091101132539.htmScienceDaily (Nov. 1, 2009) In campy old movies, Lucretia Borgia swans around emptying powder from her ring into wine glasses carelessly left unattended. The poison ring is usually a confection of gold filigree holding a cabochon or faceted gemstone that can be broken to empty the ring's contents. It is invariably enormous -- so large it is rather odd nobody seems to notice it.Mon, 02 Nov 2009 12:00:00 AM GMThttp://www.eurekalert.org/pub_releases/2009-10/acs-nmd102809.phpEurekAlert -- Scientists in California are reporting development of a new generation of the microcapsules used in carbon-free copy paper, in which capsules burst and release ink with pressure from a pen. The new microcapsules burst when exposed to light, releasing their contents in ways that could have wide-ranging commercial uses from home and personal care to medicine. Their study appears in the...Thu, 29 Oct 2009 12:00:00 AM GMThttp://www.physorg.com/news173681739.html<!-- AddThis Button BEGIN --><script type"text/javascript">var addthis_pub"bdwyer";</script><a href"http://www.addthis.com/bookmark.php?v20" onmouseover"return addthis_open(this, '', '[URL]', '[TITLE]')" onmouseout"addthis_close()" onclick"return addthis_sendto()"><img src"http://s7.addthis.com/static/btn/sm-share-en.gif" width"83" height"16" alt"Bookmark and Share" style"border:0...Fri, 02 Oct 2009 12:00:00 AM GMThttp://www.earthtimes.org/articles/show/octoplus-announces-further-efficiency-measures,972664.shtml <!-- AddThis Button BEGIN --><script type"text/javascript">var addthis_pub"bdwyer";</script><a href"http://www.addthis.com/bookmark.php?v20" onmouseover"return addthis_open(this, '', '[URL]', '[TITLE]')" onmouseout"addthis_close()" onclick"return addthis_sendto()"><img src"http://s7.addthis.com/static/btn/sm-share-en.gif" width"83" height"16" alt"Bookmark and Share" style"border...Fri, 25 Sep 2009 12:00:00 AM GMThttp://www.sciencedaily.com/releases/2009/09/090921173138.htm <!-- AddThis Button BEGIN --><script type"text/javascript">var addthis_pub"bdwyer";</script><a href"http://www.addthis.com/bookmark.php?v20" onmouseover"return addthis_open(this, '', '[URL]', '[TITLE]')" onmouseout"addthis_close()" onclick"return addthis_sendto()"><img src"http://s7.addthis.com/static/btn/sm-share-en.gif" width"83" height"16" alt"Bookmark and Share" style"border:...Tue, 22 Sep 2009 12:00:00 AM GMThttp://www.medicalnewstoday.com/articles/163268.phpMedical News Today -- There is growing market potential for the integration of electronic functionality into devices which will improve patient outcomes, says a panel of industry experts in an influential report launched today.Wed, 09 Sep 2009 12:00:00 AM GMThttp://www.biospace.com/news_story.aspx?StoryID=154067&full=1 <!-- AddThis Button BEGIN --><script type"text/javascript">var addthis_pub"bdwyer";</script><a href"http://www.addthis.com/bookmark.php?v20" onmouseover"return addthis_open(this, '', '[URL]', '[TITLE]')" onmouseout"addthis_close()" onclick"return addthis_sendto()"><img src"http://s7.addthis.com/static/btn/sm-share-en.gif" width"83" height"16" alt"Bookmark and Share" style"border...Wed, 26 Aug 2009 12:00:00 AM GMThttp://www.news-medical.net/news/20090819/Light-activated-delivery-system-enhances-anti-tumour-drug-potency.aspx<p> OSLO, August 19 /PRNewswire/ --</p><p> - PCI Biotech's Light-Activated Drug Delivery System Combines With Tumour-Targeting Drugs to Halt Tumour Growth at Low Doses</p><p> The effects of tumour-targeting drugs in mice are significantly enhanced by PCI Biotech's light-activated delivery system, a new study shows.</p><p> Researchers say this dual therapy approach could be employed to increase...Wed, 19 Aug 2009 12:00:00 AM GMThttp://www.biospace.com/news_story.aspx?StoryID=152700&full=1 <!-- AddThis Button BEGIN --><script type"text/javascript">var addthis_pub"bdwyer";</script><a href"http://www.addthis.com/bookmark.php?v20" onmouseover"return addthis_open(this, '', '[URL]', '[TITLE]')" onmouseout"addthis_close()" onclick"return addthis_sendto()"><img src"http://s7.addthis.com/static/btn/sm-share-en.gif" width"83" height"16" alt"Bookmark and Share" style"border...Mon, 10 Aug 2009 12:00:00 AM GMThttp://www.biospace.com/news_story.aspx?StoryID=151205&full=1AUSTIN, Texas, July 27 /PRNewswire/ -- Patton Medical Devices, manufacturer of the i-port and a leader of injection port therapy, announced today that they have entered into a partnership agreement with Unomedical, a leading manufacturer of single use medical devices used in the treatment of diabetes.</p><p>(Photo: http://www.newscom.com/cgi-bin/prnh/20090727/DA51373)</p><p>The two companies...Mon, 27 Jul 2009 12:00:00 AM GMThttp://www.eurekalert.org/pub_releases/2009-07/chb-adc072109.php<!-- AddThis Button BEGIN --><script type"text/javascript">var addthis_pub"bdwyer";</script><a href"http://www.addthis.com/bookmark.php?v20" onmouseover"return addthis_open(this, '', '[URL]', '[TITLE]')" onmouseout"addthis_close()" onclick"return addthis_sendto()"><img src"http://s7.addthis.com/static/btn/sm-share-en.gif" width"83" height"16" alt"Bookmark and Share" style"border:0...Wed, 22 Jul 2009 12:00:00 AM GMThttp://www.medicalnewstoday.com/articles/156614.php<!-- AddThis Button BEGIN --><script type"text/javascript">var addthis_pub"bdwyer";</script><a href"http://www.addthis.com/bookmark.php?v20" onmouseover"return addthis_open(this, '', '[URL]', '[TITLE]')" onmouseout"addthis_close()" onclick"return addthis_sendto()"><img src"http://s7.addthis.com/static/btn/sm-share-en.gif" width"83" height"16" alt"Bookmark and Share" style"border:0...Tue, 07 Jul 2009 12:00:00 AM GMThttp://www.reuters.com/article/marketsNews/idINBNG33649420090629?rpc=44 <!-- AddThis Button BEGIN --><script type"text/javascript">var addthis_pub"bdwyer";</script><a href"http://www.addthis.com/bookmark.php?v20" onmouseover"return addthis_open(this, '', '[URL]', '[TITLE]')" onmouseout"addthis_close()" onclick"return addthis_sendto()"><img src"http://s7.addthis.com/static/btn/sm-share-en.gif" width"83" height"16" alt"Bookmark and Share" style"border...Mon, 29 Jun 2009 12:00:00 AM GMThttp://www.news.cornell.edu/stories/June09/GeneTherapy.html<!-- AddThis Button BEGIN --><script type"text/javascript">var addthis_pub"bdwyer";</script><a href"http://www.addthis.com/bookmark.php?v20" onmouseover"return addthis_open(this, '', '[URL]', '[TITLE]')" onmouseout"addthis_close()" onclick"return addthis_sendto()"><img src"http://s7.addthis.com/static/btn/sm-share-en.gif" width"83" height"16" alt"Bookmark and Share" style"border:0...Fri, 26 Jun 2009 12:00:00 AM GMThttp://www.ucsc.edu/news_events/text.asp?pid=3034<!-- AddThis Button BEGIN --><script type"text/javascript">var addthis_pub"bdwyer";</script><a href"http://www.addthis.com/bookmark.php?v20" onmouseover"return addthis_open(this, '', '[URL]', '[TITLE]')" onmouseout"addthis_close()" onclick"return addthis_sendto()"><img src"http://s7.addthis.com/static/btn/sm-share-en.gif" width"83" height"16" alt"Bookmark and Share" style"border:0...Thu, 18 Jun 2009 12:00:00 AM GMThttp://www.biospace.com/news_story.aspx?StoryID=142775&full=1 <!-- AddThis Button BEGIN --><script type"text/javascript">var addthis_pub"bdwyer";</script><a href"http://www.addthis.com/bookmark.php?v20" onmouseover"return addthis_open(this, '', '[URL]', '[TITLE]')" onmouseout"addthis_close()" onclick"return addthis_sendto()"><img src"http://s7.addthis.com/static/btn/sm-share-en.gif" width"83" height"16" alt"Bookmark and Share" style"border...Fri, 29 May 2009 12:00:00 AM GMThttp://www.newscientist.com/article/mg20227096.000-spermlike-nanopropeller-is-smallest-swimmer-ever.html<!-- AddThis Button BEGIN --><script type"text/javascript">var addthis_pub"bdwyer";</script><a href"http://www.addthis.com/bookmark.php?v20" onmouseover"return addthis_open(this, '', '[URL]', '[TITLE]')" onmouseout"addthis_close()" onclick"return addthis_sendto()"><img src"http://s7.addthis.com/static/btn/sm-share-en.gif" width"83" height"16" alt"Bookmark and Share" style"border:0...Wed, 27 May 2009 12:00:00 AM GMThttp://www.medpagetoday.com/MeetingCoverage/ICD/14350MedPage Today -- PRAGUE, May 22 -- Silica-encapsulated benzoyl peroxide improved acne more with less skin irritation than a conventional form of the medication, according to results of a randomized clinical trial.Tue, 26 May 2009 12:00:00 AM GMThttp://www.earthsky.org/radioshows/53238/nanotech-tattoo-might-help-diabeticsEarth Sky -- Today, diabetics monitoring their blood sugar sometimes have to endure multiple needle pricks every day. But biomedical engineer Heather Clark of Draper Laboratory is developing a less invasive way to measure blood glucose. She describes it as a nanotech tattoo.Fri, 22 May 2009 12:00:00 AM GMThttp://www.reuters.com/article/healthNews/idUSTRE5435AO20090504 <!-- AddThis Button BEGIN --><script type"text/javascript">var addthis_pub"bdwyer";</script><a href"http://www.addthis.com/bookmark.php?v20" onmouseover"return addthis_open(this, '', '[URL]', '[TITLE]')" onmouseout"addthis_close()" onclick"return addthis_sendto()"><img src"http://s7.addthis.com/static/btn/sm-share-en.gif" width"83" height"16" alt"Bookmark and Share" style"border...Tue, 05 May 2009 12:00:00 AM GMThttp://www.newscientist.com/article/dn17071-bacteria-take-fantastic-voyage-through-bloodstream.htmlNew Scientist -- Canadian engineers have sent swimming magnetic bacteria through the bloodstreams of rats. The work is a step towards the team's goal of harnessing them as drug mules steered through human bodies using magnetic fields.Tue, 05 May 2009 12:00:00 AM GMThttp://www.biospace.com/news_story.aspx?StoryID=137865&full=1 <!-- AddThis Button BEGIN --><script type"text/javascript">var addthis_pub"bdwyer";</script><a href"http://www.addthis.com/bookmark.php?v20" onmouseover"return addthis_open(this, '', '[URL]', '[TITLE]')" onmouseout"addthis_close()" onclick"return addthis_sendto()"><img src"http://s7.addthis.com/static/btn/sm-share-en.gif" width"83" height"16" alt"Bookmark and Share" style"border...Mon, 04 May 2009 12:00:00 AM GMThttp://www.healthday.com/Article.asp?AID=626211<!-- AddThis Button BEGIN --><script type"text/javascript">var addthis_pub"bdwyer";</script><a href"http://www.addthis.com/bookmark.php?v20" onmouseover"return addthis_open(this, '', '[URL]', '[TITLE]')" onmouseout"addthis_close()" onclick"return addthis_sendto()"><img src"http://s7.addthis.com/static/btn/sm-share-en.gif" width"83" height"16" alt"Bookmark and Share" style"border:0...Mon, 27 Apr 2009 12:00:00 AM GMThttp://www.nanowerk.com/spotlight/spotid=10275.php<!-- AddThis Button BEGIN --><script type"text/javascript">var addthis_pub"bdwyer";</script><a href"http://www.addthis.com/bookmark.php?v20" onmouseover"return addthis_open(this, '', '[URL]', '[TITLE]')" onmouseout"addthis_close()" onclick"return addthis_sendto()"><img src"http://s7.addthis.com/static/btn/sm-share-en.gif" width"83" height"16" alt"Bookmark and Share" style"border:0...Mon, 27 Apr 2009 12:00:00 AM GMThttp://www.medicalnewstoday.com/articles/146811.phpMedical News Today -- An interdisciplinary team of researchers at Brigham and Women's Hospital (BWH) and the Harvard-MIT Division of Health Sciences and Technology has demonstrated a better way to deliver cancer drugs directly to tumors by using specially engineered nanoparticles that can inhibit a signaling pathway and deliver a higher concentration of medication to the specific area. Details of their...Wed, 22 Apr 2009 12:00:00 AM GMThttp://www.eurekalert.org/pub_releases/2009-04/aafc-bd041309.phpEurekAlert! -- DENVER Researchers may have found a way to combine imaging with chemotherapy in a single agent for the treatment of prostate cancer, according to data presented at the American Association for Cancer Research 100th Annual Meeting 2009.Wed, 22 Apr 2009 12:00:00 AM GMThttp://www.sciencedaily.com/releases/2009/04/090415162651.htmScienceDaily (Apr. 20, 2009) Gastroenterologists at Rush University Medical Center are studying the safety and efficacy of a new system for delivering chemotherapy for patients with esophageal cancer, a rare, but deadly disease that attacks the throat. The unique drug therapy delivers a highly concentrated dose of chemotherapy injected directly on to the hard-to-reach tumors in the esophagus non...Mon, 20 Apr 2009 12:00:00 AM GMThttp://www.eurekalert.org/pub_releases/2009-03/uof-cl032509.phpEurekAlert -- Scientists have shed new light -- literally -- on a possible way to starve cancer tumors or prevent side effects from a wide range of drugs. A lock-like molecule designed by University of Florida chemistry researchers clasps or unclasps based on exposure to light. In laboratory tests, the chemists put the lock on an enzyme involved in blood clotting. They then exposed the enzyme to visible...Tue, 31 Mar 2009 12:00:00 AM GMThttp://www.biospace.com/news_story.aspx?StoryID=130221&full=1 LAKE FOREST, Calif.--(BUSINESS WIRE)--I-Flow Corporation (NASDAQ:IFLO - News), through its wholly-owned subsidiary AcryMed Inc., announced today that it received 510(k) clearance on February 26, 2009 from the Food and Drug Administration (FDA) for its stabilized antimicrobial wound gel. The product, as yet unnamed, has been FDA cleared for both over-the-counter and prescription-only marketing and...Thu, 12 Mar 2009 12:00:00 AM GMThttp://www.eurekalert.org/pub_releases/2009-03/w-bsa030609.phpEurekAlert! -- Amphiphilic molecules, which have one water-friendly (hydrophilic) end and one water-repellant (hydrophobic) end, spontaneously aggregate in aqueous solutions to make superstructures like capsules or bilayers. This phenomenon is responsible for the effects of detergents and soaps. Dirt is enclosed in little capsules of surfactant, which makes it water-soluble. Cell membranes are also...Fri, 06 Mar 2009 12:00:00 AM GMThttp://www.sciencedaily.com/releases/2009/02/090222142127.htmScienceDaily (Mar. 1, 2009) Small is promising when it comes to illuminating tiny tumors or precisely delivering drugs, but many worry about the safety of nano-scale materials. Now a team of scientists has created minuscule flakes of silicon that glow brightly, last long enough to slowly release cancer drugs, then break down into harmless by-products.Mon, 02 Mar 2009 12:00:00 AM GMThttp://www.nanotech-now.com/news.cgi?story_id=32202Nanotechnology -- Microscopic, living machines that sense toxins in the air or deliver drugs in the body -- the stuff of science fiction? A new Cornell student project team is working to make such things the stuff of reality. The Cornell International Genetically Engineered Machines (iGEM) team, formed this year, uses biological, not mechanical, components to make machines. Their goal is to enter...Wed, 18 Feb 2009 12:00:00 AM GMThttp://www.eurekalert.org/pub_releases/2009-02/ip-wdc020609.phpEurekAlert! -- Electronic implants that dispense medicines automatically or via a wireless medical network are on the horizon. Australian and US researchers warn of the security risks in a forthcoming issue of the International Journal of Biomedical Engineering and Technology.Fri, 06 Feb 2009 12:00:00 AM GMThttp://publicaffairs.uth.tmc.edu/media/newsreleases/nr2009/nano_outcome.htmUniversity of Texas Health Science Center -- HOUSTON (Feb. 4, 2009) Scientists including one from The University of Texas Health Science Center at Houston successfully predicted the outcome of a nano drug on breast tumors in a pre-clinical study. Their research could help determine which patients will respond best to cancer-fighting nano drugs.Fri, 06 Feb 2009 12:00:00 AM GMThttp://www.biospace.com/news_story.aspx?StoryID=123296&full=1AUSTIN, TX January 19, 2009 - Specialty coatings company, AeonClad Coatings LLC, has announced the launch of a newly formed subsidiary, AeonClad Biomedical LLC. The new company will focus on biomedical applications utilizing the AeonCoat Technology. AeonCoat is a dry coating technology that offers a single-step, solvent-free process producing conformal films. The technology enables custom tailored...Tue, 20 Jan 2009 12:00:00 AM GMThttp://www.healthday.com/Article.asp?AID=623188TUESDAY, Jan. 20 (HealthDay News) -- A minimally invasive therapy that uses beads soaked with anti-cancer agents has been successful at halting liver tumors, according to new studies.Tue, 20 Jan 2009 12:00:00 AM GMThttp://www.biospace.com/news_story.aspx?StoryID=122910&full=1<p>Data demonstrates that new Cobalamin oral insulin and oral human growth hormone formulations provide significant pharmacological responses in preclinical models</p><p></p><p>DALLAS, Jan. 14 /PRNewswire-FirstCall/ -- ACCESS PHARMACEUTICALS, INC. provided an update today on its Cobalamin(TM) oral drug delivery product development programs. The proprietary Cobalamin(TM) technology utilizes the body...Wed, 14 Jan 2009 12:00:00 AM GMThttp://www.sciencedaily.com/releases/2009/01/090112121815.htmPenn State -- University Park, Pa. -- A tiny particle syringe composed of polymer layers and nanoparticles may provide drug delivery that targets diseased cells without harming the rest of the body, according to a team of chemical engineers. This delivery system could be robust and flexible enough to deliver a variety of substances.Tue, 13 Jan 2009 12:00:00 AM GMThttp://www.biospace.com/news_story.aspx?StoryID=122001&full=1RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--Liquidia Technologies, Inc. announced today that it has entered into a collaboration and license agreement with Abbott to develop PRINT nanoparticles for the delivery of siRNA-based therapeutics. Liquidias PRINT technology offers the ability to fabricate nanoparticles of precisely defined size, shape, surface chemistry, and composition, which offers...Wed, 07 Jan 2009 12:00:00 AM GMThttp://web.mit.edu/newsoffice/2008/nanorods-1230.htmlMIT -- Using tiny gold particles and infrared light, MIT researchers have developed a drug-delivery system that allows multiple drugs to be released in a controlled fashion.Fri, 02 Jan 2009 12:00:00 AM GMThttp://www.pehub.com/26753/entra-pharma-raises-first-round/Entra Pharmaceuticals Inc., a Waltham, Mass.-based drug delivery startup, has raised $4.23 million in the first tranche of its Series A round, according to a regulatory filing.Thu, 18 Dec 2008 12:00:00 AM GMThttp://www.sciencedaily.com/releases/2008/12/081215151147.htmScienceDaily (Dec. 15, 2008) Researchers in Pennsylvania are reporting for the first time that nanoparticles 1/5,000 the diameter of a human hair encapsulating an experimental anticancer agent, kill human melanoma and drug-resistant breast cancer cells growing in laboratory cultures.Tue, 16 Dec 2008 12:00:00 AM GMThttp://www.biospace.com/news_story.aspx?StoryID=120604&full=1WATERTOWN, Mass.--(BUSINESS WIRE)--Drug delivery company pSivida Corp (NASDAQ: PSDV - News)(ASX: PVA - News)(FF: PV3) has entered into a technology evaluation agreement to evaluate cardiovascular delivery of drugs using pSividas drug delivery technologies.</p><p>This is pSividas first cardiovascular application as the company is mostly known for its ocular drug delivery. This evaluation is being...Tue, 16 Dec 2008 12:00:00 AM GMThttp://www.biospace.com/news_story.aspx?StoryID=120453&full=1LOD, Israel--(BUSINESS WIRE)--TransPharma Medical Ltd., a specialty pharmaceutical company focused on the development and commercialization of drug products utilizing a proprietary active transdermal drug delivery technology, announced today that it received European CE Mark approval for its ViaDerm, a transdermal drug delivery device.</p><p>"We are excited about receiving the European CE approval...Mon, 15 Dec 2008 12:00:00 AM GMThttp://www.biospace.com/news_story.aspx?StoryID=120251&full=1<p> VIENNA, Austria, Dec. 11 /PRNewswire/ -- Intercell AG (VSE: ICLL) today announced the execution of a contract modification with the U.S. Department of Health and Human Services (HHS). The agreement commits additional funding of USD 12.5 m for Intercell's Pandemic Influenza program.</p><p> Intercell is developing a Pandemic Influenza Vaccine Patch System that includes an immunostimulant patch...Thu, 11 Dec 2008 12:00:00 AM GMThttp://www.businesswire.com/portal/site/biospace/index.jsp?ndmViewId=news_view&newsId=20081202005195&newsLang=enRALEIGH, N.C.--(BUSINESS WIRE)--NanoVector, Inc. announced today that it has licensed the plant virus nanoparticle drug delivery system developed by Professors Stefan Franzen and Steven Lommel from North Carolina State University. This is breakaway technology that will finally provide the highly sought after selective targeting of tumors and intracellular delivery of anti-cancer agents for improved...Tue, 02 Dec 2008 12:00:00 AM GMThttp://www.forbes.com/feeds/ap/2008/11/21/ap5726467.htmlEDEN PRAIRIE, Minn.--(BUSINESS WIRE)--SurModics, Inc. (Nasdaq: SRDX - News), a leading provider of drug delivery and surface modification technologies to the healthcare industry, today announced changes designed to improve the Companys ability to meet the growing needs of its customers while more effectively managing its operations and cost structure.</p><p>SurModics will now be organized into...Fri, 21 Nov 2008 12:00:00 AM GMT